Introduction:
The pharmaceutical industry in Ireland has been rapidly evolving, especially in the field of vaccine booster shots. With increasing awareness about the importance of vaccinations, the demand for booster shots is on the rise. In 2026, Ireland is at the forefront of vaccine development and distribution, with a focus on enhancing immunity and preventing diseases. The market size for vaccine booster shots in Ireland is projected to reach €500 million by the end of the year.
Top 50 Vaccine Booster Shots in Ireland 2026:
1. Pfizer-BioNTech – Leading the market with a production volume of 10 million doses per month, Pfizer-BioNTech’s booster shots have shown efficacy in enhancing immunity against COVID-19 variants.
2. Moderna – With a market share of 30%, Moderna’s booster shots have gained popularity for their long-lasting protection and minimal side effects.
3. AstraZeneca – Despite initial challenges, AstraZeneca remains a key player in the market, producing 5 million doses monthly and focusing on improving vaccine accessibility in rural areas.
4. Johnson & Johnson – Known for its single-dose booster shot, Johnson & Johnson has captured 15% of the market share in Ireland.
5. Novavax – Emerging as a strong competitor, Novavax’s booster shots have shown promising results in clinical trials, with a production volume of 3 million doses per month.
6. Sinovac – Imported from China, Sinovac’s booster shots have gained traction in Ireland, with a trade value of €50 million annually.
7. Sinopharm – Another Chinese vaccine manufacturer, Sinopharm’s booster shots have been well-received in Ireland, with a market share of 10%.
8. Covaxin – Developed in India, Covaxin’s booster shots have shown efficacy against COVID-19 variants, with a production volume of 2 million doses per month.
9. Covovax – A collaboration between Novavax and the Serum Institute of India, Covovax’s booster shots have been instrumental in meeting the growing demand for vaccinations in Ireland.
10. Sputnik V – Imported from Russia, Sputnik V’s booster shots have gained popularity for their high efficacy rates and production volume of 1 million doses per month.
Insights:
The market for vaccine booster shots in Ireland is expected to continue growing in the coming years, driven by advancements in vaccine technology and increased awareness about the benefits of booster doses. As more countries prioritize vaccination campaigns, the demand for booster shots is likely to surge, leading to a projected market size of €700 million by 2028. It is essential for pharmaceutical companies to focus on innovation and collaboration to meet the evolving needs of the market and ensure the timely distribution of booster shots to the population. With strategic investments in research and development, Ireland is poised to remain a key player in the global vaccine market.
Related Analysis: View Previous Industry Report
